Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.7500
-0.1610 (-17.67%)
At close: Apr 1, 2025, 4:00 PM
0.8641
+0.1141 (15.22%)
After-hours: Apr 1, 2025, 4:17 PM EDT
Cue Biopharma Stock Forecast
CUE's stock price has decreased by -57.66% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Cue Biopharma stock have an average target of 4.75, with a low estimate of 2.00 and a high estimate of 10. The average target predicts an increase of 533.33% from the current stock price of 0.75.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 20, 2024.
Analyst Ratings
The average analyst rating for Cue Biopharma stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $8 → $4 | Strong Buy | Maintains | $8 → $4 | +433.33% | Aug 20, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $15 → $2 | Buy | Maintains | $15 → $2 | +166.67% | Jul 26, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $8 → $3 | Buy | Maintains | $8 → $3 | +300.00% | Jul 26, 2024 |
| Stifel | Stifel | Strong Buy Maintains $8 | Strong Buy | Maintains | $8 | +966.67% | Apr 9, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $10 | Buy | Maintains | $10 | +1,233.33% | Apr 9, 2024 |
Financial Forecast
Revenue This Year
10.55M
from 9.29M
Increased by 13.61%
Revenue Next Year
19.21M
from 10.55M
Increased by 82.06%
EPS This Year
-0.56
from -0.72
EPS Next Year
-0.47
from -0.56
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 24.9M | 47.3M | 26.3M | ||
| Avg | 10.6M | 19.2M | 17.0M | ||
| Low | n/a | 8.5M | 8.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 168.5% | 347.8% | 36.7% | ||
| Avg | 13.6% | 82.1% | -11.7% | ||
| Low | - | -19.1% | -55.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.42 | -0.24 | -0.51 | ||
| Avg | -0.56 | -0.47 | -0.49 | ||
| Low | -0.64 | -0.58 | -0.48 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.